As of Nov 15
| -0.12 / -4.41%|
The 4 analysts offering 12-month price forecasts for Alpine Immune Sciences Inc have a median target of 13.00, with a high estimate of 17.00 and a low estimate of 8.00. The median estimate represents a +400.00% increase from the last price of 2.60.
The current consensus among 4 polled investment analysts is to Buy stock in Alpine Immune Sciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.